Intracellular Localization of the Epstein-Barr Virus BFRF1 Gene Product in Lymphoid Cell Lines and Oral Hairy Leukoplakia Lesions

Journal of Medical Virology

Volumn 72, Issue 1, 2004, Pages 102-111

  Farina, Antonella ^a   Cardinali, Giorgia ^b   Santarelli, Roberta ^a   Gonnella, Roberta ^a   Webster Cyriaque, Jennifer ^c   Bei, Roberto ^d   Muraro, Raffaella ^e   Frati, Luigi ^a,f   Angeloni, Antonio ^a   Torrisi, Maria Rosaria ^a,b   Faggioni, Alberto ^a,g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f IRCCS NEUROMED   (Italy)

^g Dipartimento di Medicina Sperimentale e Patologia   (Italy)

Author keywords

BFRF1; EBV; Immunoelectron microscopy; Immunofluorescence; Nuclear membrane; Oral hairy leukoplakia; UL 34 homologues; Viral envelopment

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN G ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOPROTEIN; PROTEIN BFRF1; UNCLASSIFIED DRUG;

ARTICLE; BURKITT LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL STIMULATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE LOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGOLD ELECTRON MICROSCOPY; LEUKOPLAKIA; LYMPHOID CELL LINE; LYMPHOMA CELL LINE; MOUTH LESION; MUTANT; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; VIRUS ASSEMBLY; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

BIOPSY; CELL LINE; CELL LINE, TRANSFORMED; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOPLAKIA, HAIRY; LYMPHOID TISSUE; MICROSCOPY, IMMUNOELECTRON; MOUTH MUCOSA; NUCLEAR ENVELOPE; SUBCELLULAR FRACTIONS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTOR TFIIIB; VIRUS ASSEMBLY;

HUMAN HERPESVIRUS 4;

EID: 10744233854     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10561     Document Type: Article

References (24)

1. Angeloni A, Farina A, Gentile G, Capobianchi A, Martino P, Visco V, Muraro R, Frati L, Faggioni A. 2001. Epstein-Barr virus and breast cancer: search for antibodies to the novel BFRF1 protein in sera of breast cancer patients. J Natl Cancer Inst 93:560-561.
2. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci USA 95:8245-8250.
3. Farina A, Santarelli R, Gonnella R, Bei R, Muraro R, Cardinali G, Uccini S, Ragona G, Frati L, Faggioni A, Angeloni A. 2000. The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol 74:3235-3244.
4. Fuchs W, Klupp BG, Granzow H, Osterreider N, Mettenleiter TC. 2002. The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary envelopes but not of mature virions. J Virol 71:364-378.
5. Gong M, Kieff E. 1990. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp 350/220 and gp110. J Virol 64:1507-1516.
6. Granzow H, Weiland F, Jons A, Klupp BG, Karger A, Mettenleiter TC. 1997. Ultrastructural analysis of the replication cycle of pseudorabies virus in cell culture: a reassessment. J Virol 71:2072-2082.
7. Janz A, Oezel M, Kurzeder C, Mautner J, Pich D, Kost M, Hammerschmidt M, Delecluse HJ. 2000. Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol 74:10142-10152.
8. Klupp BG, Granzow H, Mettenleiter TC. 2000. Primary envelopment of pseudorabies virus at the nuclear membrane requires the UL34 gene product. J Virol 74:10063-10073.
9. Lake CM, Hutt-Fletcher LM. 2000. Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infection. J Virol 74:11162-11172.
10. Lee SK, Longnecker R. 1997. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J Virol 71:4092-4097.
11. Mackett M, Conway MJ, Arrand JR, Haddad RS, Hutt-Fletcher LM. 1990. Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment. J Virol 64:2545-2552.
12. Mettenleiter TC. 2002. Herpesvirus assembly and egress. J Virol 76:1537-1547.
13. Neubauer A, Rudolph J, Brandmuller C, Just FT, Osterreider N. 2002. The equine herpesvirus 1 UL34 gene product is involved in an early step in virus egress and can be efficiently replaced by a UL34-GFP fusion protein. Virology 300:189-204.
14. Penaranda ME, Lagenaur LA, Pierek LT, Berline JW, MacPhail LA, Greenspan D, Greenspan J, Palefsky JM. 1997. Expression of Epstein-Barr virus BMFR-2 and BDLF-3 genes in hairy leukoplakia. J Gen Virol 78:3361-3370.
15. Reynolds AE, Ryckman BJ, Baines JD, Zhou Y, Liang L, Roller RJ. 2001. UL31 and UL34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids. J Virol 75:8803-8817.
16. Roller R, Zhou Y, Schnetzer R, Ferguson J, DeSalvo D. 2000. Herpes simplex virus type 1 UL34 gene product is required for viral envelopment. J Virol 74:117-129.
17. Shiba C, Daikoku T, Goshima F, Takakuwa H, Yamauchi Y, Koiwai O, Nishiyama Y. 2000. The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for viral envelopment. J Gen Virol 81:2397-2405.
18. Torrisi MR, Cirone M, Pavan A, Zompetta C, Barile G, Frati L, Faggioni A. 1989. Localization of Epstein-Barr virus envelope glycoproteins on the inner nuclear membrane of virus producing cells. J Virol 63:828-832.
19. Torrisi MR, Gentile M, Cardinali G, Cirone M, Zompetta C, Lotti LV, Frati L, Faggioni A. 1999. Intracellular transport and maturation pathway of human herpesvirus 6. Virology 257:460-471.
20. Webster-Cyriaque J, Raab-Traub N. 1998. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Virology 248:53-65.
21. Webster-Cyriaque J, Edwards RH, Quinlivan EB, Patton L, Wohl D, Raab-Traub N. 1997. Epstein-Barr virus and human herpes virus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions. J Infect Dis 175:1324-1332.
22. Webster-Cyriaque J, Middeldorp JM, Raab-Traub N. 2000. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infection. J Virol 74:7610-7618.
23. Yamauchi Y, Shiba C, Goshima F, Nawa A, Murata T, Nishiyama T. 2001. Herpes simplex virus type 2 UL34 protein requires UL31 protein for its relocation to the internal nuclear membrane in transfected cells. J Gen Virol 82:1423-1428.
24. Ye GJ, Vaughan KT, Vallee RB, Roizman B. 2000. The herpes simplex virus 1 UL34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane. J Virol 74:1355-1363.